Articles related to INSURANCE
What Clinicians Need to Know About the DSM-5-TR Updates
With regard to his panel, “DSM-5 Text Revision (DSM-5-TR): What’s New and What’s Different,” which was presented at Psych Congress Elevate 2022, Michael B. First, MD, professor of clinical psychiatry at Columbia University in New York City, and editor and co-chair of the DSM-5-TR, responds to questions in this Q&A. The updated text’s main revisions to the “Introduction” and “Use” sections are discussed by Dr. First, who also explains the new diagnoses it now includes and provides his thoughts on how the enhanced text will help psychiatrists in their daily work.
Psychiatry July 26th 2022
The No Surprises Act is Receiving Push Back—Here’s Why
The No Surprises Act, which went into effect on January 1, 2022, serves patients by legally protecting them from unexpected bills after receiving “emergency care, non-emergency care from out-of-network providers at in-network facilities, and air ambulance services from out-of-network providers.” But there are some doctors, like this acute-care surgeon, who believes the act is unconstitutional and is taking the federal government to court.
Emergency Medicine June 23rd 2022
10-year review of health insurance data set reveals possible protective effect of H1 antihistamines in preventing hepatic cancer
Antihistamine use in patients with HBV, HCV, or dual virus infections was associated with approximately two-fold lower risk of HCC when compared with patients who did not use antihistamines, in a dose-dependent manner.
Oncology, Medical May 10th 2022
Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance
In a study of parenteral cancer drug pricing at 61 NCI-designated cancer centers, median price markups on 25 commonly used drugs ranged from approximately 120% to 630% over acquisition cost. The paper’s authors recommend public policy prohibiting excessive markup on parenteral chemotherapies as a means to reduce unnecessary financial burden on patients.
Oncology, Medical April 26th 2022
Mark Cuban’s Pharmacy: Disrupting Outsized Generic Drug Costs
Billionaire entrepreneur Mark Cuban is well-known for appearing on the television show Shark Tank and as the owner of the NBA’s Dallas Mavericks. Now, Cuban is taking on generic drug price inflation with the launch of his own pharmacy called the Mark Cuban Cost Plus Drug Company (MCCPDC), which is bypassing the PBM and lowering the cost of generic prescriptions for consumers.
All Specialties March 1st 2022